Pharmacokinetic Drug Interactions with Oral Contraceptives
- 130 Downloads
Oral contraceptive steroids are used by an estimated 60 to 70 million women worldwide. Over the past 20 years there have been both case reports and clinical studies on the topic of drug interactions with these agents. Some of the interactions are of definite therapeutic relevance, whereas others can be discounted as being of no clinical significance. Pharmacological interactions between oral contraceptive steroids and other compounds may be of 2 kinds: (a) drugs may impair the efficacy of oral contraceptive steroids, leading to breakthrough bleeding and pregnancy (in a few cases, the activity of the contraceptive is enhanced); (b) oral contraceptive steroids may interfere with the metabolism of other drugs.
A number of anticonvulsants (phenobarbital, Phenytoin, carbamazepine) are enzymeinducing agents and thereby increase the clearance of the oral contraceptive steroids. Valproic acid has no enzyme-inducing properties, and thus women on this anticonvulsant can rely on their low dose oral contraceptive steroids for contraceptive protection. Researchers are now beginning to unravel the molecular basis of this interaction, with evidence of specific forms of cytochrome P450 (P450IIC and IIIA gene families) being induced by phenobarbital. Rifampicin, the antituberculous drug, also induces a cytochrome P450 which is a product of the P450IIIA gene subfamily. This isozyme is one of the major forms involved in 2-hydroxylation of ethinylestradiol.
Broad spectrum antibiotics have been implicated in causing pill failure; case reports document the interaction, and general practitioners are convinced that it is real. The problem remains that there is still no firm clinical pharmacokinetic evidence which indicates that blood concentrations of oral contraceptive steroids are altered by antibiotics. However, perhaps this should not be a surprise, given that the incidence of the interaction may be very low. It is suggested that an individual at risk will have a low bioavailability of ethinylestradiol, a large enterohepatic recirculation and gut flora particularly susceptible to the antibiotic being used.
Two drugs, ascorbic acid (vitamin C) and paracetamol (acetaminophen), give rise to increased blood concentrations of ethinylestradiol due to competition for sulphation. The interactions could have some significance to women on oral contraceptive steroids who regularly take high doses of either drug. Although on theoretical grounds adsorbents (e.g. magnesium trisilicate, aluminium hydroxide, activated charcoal and kaolin) could be expected to interfere with oral contraceptive efficacy, there is no firm evidence that this is the case. Similarly, there is no evidence that smoking alters the pharmacokinetics of oral contraceptive steroids.
These agents are now well documented as being able to alter the pharmacokinetics of other concomitantly administered drugs. The clearance of a number of benzodiaze-pines undergoing oxidation (chlordiazepoxide, alprazolam, diazepam) and nitro reduction (nitrazepam), theophylline, prednisolone, caffeine and cyclosporin, is reduced in oral contraceptive steroid users. The clearance of some drugs undergoing glucuronidation (temazepam, salicylic acid, paracetamol, morphine, clofibric acid) is apparently increased.
Unable to display preview. Download preview PDF.
- Back DJ, Bates M, Breckenridge AM, Crawford FE, Ellis A, et al. Metabolism by gastrointestinal mucosa-clinical aspects. In Prescott & Nimmo (Eds) Drug absorption, pp. 80–87, ADIS Press, Sydney, 1980bGoogle Scholar
- Back DJ, Breckenridge AM, Orme ML’E. Drug interactions with oral contraceptives. International Planned Parenthood Federation 17: 1–2, 1983Google Scholar
- Ball SE, Forrester LM, Wolf CR, Back DJ. Differences in the cytochrome P450 isozymes involved in the 2-hydroxylation of estradiol and 17α-ethinyloestradiol: relative activities of rat and human liver enzymes. Biochemical Journal, in press, 1990Google Scholar
- Chapman CR. Absorption and metabolism of steroid prodrugs. Ph. D Thesis. University of Liverpool. 1981Google Scholar
- Combalben J, Fahre I, Febre G, Dalet I, Deraneourl J, et al. Metabolism of cyclosporin A, IV. Purification and identification of the rifampicin-mduciblc human liver cytochrome P-450 (Cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metabolism and Disposition 17: 197–207, 1989Google Scholar
- Crawford P, Chadwick DJ, Martin C, Tjia J, Back DJ, et al. The interaction of Phenytoin and carbamazepine with combined oral contraceptives. British Journal of Clinical Pharmacology ((l/c))Google Scholar
- De Sano EA, Hurley SC. Possible interactions of antihistamincs and antibiotics with oral contraceptive effectiveness. Fertility and Slenlity 37: 853–854, 1982Google Scholar
- Fevcry J, van Stccnncrgen W, Desmet V. Severe intrahepatic cholestasis due to the combined intake of oral contraceptives and triaceiyloleandomycin. Acta Ctinica Belgica 38: 242–245, 1983Google Scholar
- Friedman CI, Huneke AL, Kim MH, Powell J. The effect of ampicillm on oral contraceptive effectiveness. Obstetrics and Gvnecology 55: 33–37, 1980Google Scholar
- Guengench FR. Oxidation of 17α-clhynylestradiol by human liver cytochrome P-450. Molecular Pharmacology 33: 500–508, 1988Google Scholar
- Haber I, Hubens H. Cholestatic jaundice after triacetyloleandomycin and oral contraceptives. Acta Gastroentcrologica Belgica 43: 475–482, 1980Google Scholar
- Hempel Von E, Bohm W, Carol W, Klinger W, Meditamentose Enzyminduktion und hormonale Kontrazeption. Zenlrablail fur Gynakologie 95: 1451–1457, 1973Google Scholar
- Janz D, Schmidt D. Antiepileptic drugs and failure of oral contraceptives. Lancet 1: 113, 1974Google Scholar
- Joshi JV, Sankholi GM, Shar RS, Joshi UM. Antacid does not reduce the bioavailability of oral contraceptive steroids in women. International Journal of Clinical Pharmacology. Therapeutics and Toxicology 24: 192–195, 1986Google Scholar
- Jusko WJ, Schentag JJ, Clark JH, Gardner M, Yurchak A. Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clinical Pharmacology and Therapeutics 24: 406–410, 1978Google Scholar
- Kronbach T, Fischer V, Meyer UA. Cyclosporinc metabolism in human liver: identification of a cytochrome P450III gene family as the major cyclosporine-metabolizingenzyme explains interactions of cyclosporine with other drugs. Clinical Pharmacology and Therapeutics 43: 630–635, 1988PubMedCrossRefGoogle Scholar
- Lumley CE, Walker SR, Hall GC, Siaunton N, Grob PR. The under-reporting of adverse drug reactions seen in general practice. Pharmaceutical Medicine 1: 205–212, 1986Google Scholar
- Orme ML’E, Back DJ. Drug interactions with oral contraceptive steroids. Pharmacy International 1: 38–41, 1980Google Scholar
- Reimers D, Jezek A. Rifampicin und andere Antituberkulostatika bei gleichzeitiger oraler Kontrazeption. Praxis und Klinik der Pneumologie 25: 255–262, 1981Google Scholar
- Szoka PR, Edgren RA. Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database. Fertility and Sterility 49: 31–38S, 1988Google Scholar
- Van Dijkc CPH, Weber JCP. Interaction between oral contraceptives and griseofulvin. British Medical Journal 288: 1125–1126, 1984Google Scholar
- Watson KJR, Ghabrial H, Mashford ML, Harman PJ, Brccn KJ, et al. The oral contraceptive pill increases morphine clearance but docs not increase hepatic blood flow. Gaslroentcrology 90: 1779, 1986Google Scholar